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The radiation-induced bystander effect is defined as ‘‘the induction
of biological effects in cells that are not directly traversed by a
charged particle but are in close proximity to cells that are.’’
Although these bystander effects have been demonstrated with a
variety of biological endpoints in both human and rodent cell lines
(as well as in 3D tissue samples), the mechanism of the phenom-
enon is not known. Although gap junction communication and the
presence of soluble mediator(s) are both known to play important
roles in the bystander response, the precise signaling molecules
have yet to be identified. By using the Columbia University charged
particle beam in conjunction with a strip dish design, we show here
that the cyclooxygenase-2 (COX-2, also known as prostaglandin
endoperoxide synthase-2) signaling cascade plays an essential role
in the bystander process. Treatment of bystander cells with NS-398,
which suppresses COX-2 activity, significantly reduced the by-
stander effect. Because the critical event of the COX-2 signaling is
the activation of the mitogen-activated protein kinase pathways,
our finding that inhibition of the extracellular signal-related kinase
phosphorylation suppressed bystander response further con-
firmed the important role of mitogen-activated protein kinase
signaling cascade in the bystander process. These results provide
evidence that the COX-2-related pathway, which is essential in
mediating cellular inflammatory response, is the critical signaling
link for the bystander phenomenon.
Ionizing radiation is a well established human carcinogen.Established dogma has relied on the assumption that DNA of
the nucleus is the main target for radiation-induced genotoxicity
and carcinogenesis. At doses above 50 millisievert, the radiation-
induced cancer risk can be estimated based on the cancer
incidence among the Japanese atomic bomb survivors (1, 2). At
lower doses, because fewer cells are likely to be directly dam-
aged, the deleterious effect of radiation is expected to decline
proportionally as well. However, evidence accumulated over the
past decade has indicated that both extranuclear targets and
extracellular events may play an important role in determining
the biological responses to ionizing radiation (3–6). A major
paradigm shift in radiation biology in the last decade has resulted
from work involving the bystander effect (see refs. 7 and 8 for
a review), which could have an important impact on our thinking
as well as immediate application in radiation protection.
Radiation-induced bystander effect is defined as the induction
of biological effects in cells that are not directly traversed by a
charged particle but are in close proximity to cells that are, or
have received signals from, these irradiated cells. There is
evidence that very low doses of -particles induced clastogenic
responses (principally sister chromatid exchanges) in both Chi-
nese hamster ovary (CHO) and human fibroblast cultures at
levels significantly higher than expected based on the number of
cellular nuclei that had been traversed by a particle (3, 5, 9). In
CHO cells irradiated with low doses of  particles where 1%
of the nuclei were estimated to have been traversed by a particle,
an increase in sister chromatid exchanges was observed in30%
of the cells (3). In other words, either cytoplasmic damages or
signals received from an extracellular component may have
modulated the observed genotoxic response. Although circum-
stantial evidence in support of a bystander effect appears to be
consistent, direct proof of such extranuclear and extracellular
effects is most convincingly demonstrated by using charged
particle microbeams (4, 10–12).
Results from experiments using microbeam provide evi-
dence that the bystander effects can be demonstrated by using
a variety of endpoints of biological damage, including micro-
nucleus induction, cell lethality, gene expression, mutation,
and oncogenic transformation (10–15) in various human and
rodent cell lines. Many of these bystander effects resembled
those phenotypes seen in cells that are directly irradiated,
albeit in the absence of any dose–response relationship. It has
been shown, for example, that irradiation of 10% of a conf lu-
ent human hamster hybrid (AL) cell population with a single
 particle per nucleus results in a mutant yield similar to that
observed when all of the cells in the population are irradiated
(4). A similar observation has also been made by using primary
human bronchial epithelial cells and incorporating G2 phase
premature chromosome condensation as an endpoint (16).
Furthermore, the use of AL cells that are dominant negative for
connexin 43 and lack gap junction formation demonstrated an
attenuated bystander mutagenic effect (4).
There is also evidence that media from irradiated culture
(upon transferal to nonirradiated cells) can induce biological
effects in the latter. Mothersill and Seymour first demonstrated
a highly significant reduction in cloning efficiency in both
nonirradiated normal as well as malignant epithelial cell lines
that had received media from 60Co--ray-irradiated cultures
(17). These results suggested that irradiated cells secreted a
cytotoxic factor into the culture medium, which was capable of
killing nonirradiated cells. Furthermore, transferring media
from low linear energy transfer-irradiated cultures to nonirra-
diated cells lead to increased levels of various bystander effects,
such as cell killing (18–20), neoplastic transformation (21), and
genomic instability (22). In contrast, in feeder layer culture,
metabolic cooperation between cells of similar or different types
increases the clonogenic survival of the nonirradiated cells by
providing growth factors and matrix support and is considered
a positive aspect of the bystander phenomenon.
Although the bystander effects have been well described over
the past decade, the mechanisms of the process remain unclear.
In subconfluent cultures, there is evidence that reactive oxygen
species, nitric oxide, and cytokines such as TGF are involved in
mediating the process (19, 23, 24). On the other hand, gap
junction-mediated cell–cell communications have been shown to
be critical in mediating bystander effects in confluent cultures of
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either human (25) or rodent cells (4, 10). It is likely that a
combination of pathways involving both primary and secondary
signaling processes is involved in producing a bystander process.
In the present study, we used a strip dish method to demonstrate
the induction of bystander hypoxanthine-guanine phosphoribo-
syltransferase (HPRT) mutations among the nonirradiated
primary human lung fibroblasts. Microarray analyses of differ-
entially expressed genes among the bystander cells showed a
3-fold overexpression of cyclooxygenase-2 (COX-2). Further-
more, suppression of COX-2 activity in bystander cells by using
the chemical inhibitor NS-398 significantly reduced the by-
stander effect. Because the critical event of the COX-2 signaling
pathway is activation of the mitogen-activated protein kinase
(MAPK) pathways, such as extracellular signal-related kinase
(ERK), c-Jun N-terminal kinase, and p38 kinase, we found that
inhibition of ERK phosphorylation similarly suppressed the
bystander response. These results provide evidence that the
COX-2 signaling pathway, which is essential in mediating a
cellular inflammatory response, may be a critical signaling event
for producing a bystander effect.
Materials and Methods
Cell Culture. Normal human lung fibroblasts (NHLF) in frozen
vials were purchased from Cambrex BioScience (Walkersville,
MD). The NHLF cells were thawed and maintained in a
fibroblast basal medium supplemented with 2% FBS and other
growth additives, including bovine insulin, human fibroblast
growth factor-, gentamycin sulfate, and amphotercin-B, as
supplied by the manufacturer. Cultures were maintained at 37°C
in a humidified 5% CO2 incubator. The medium was changed
every 3 days, and the cells were passaged at confluence.
Irradiation Procedure. The newly designed strip mylar dishes were
used in the present studies. Briefly, two concentric stainless steel
rings were fitted with mylar bottoms with the outer and inner
rings covered by a 6- and 38-m-thick mylar sheet, respectively.
The thicker mylar sheet of the inner ring was sliced into strips as
shown in Fig. 1. The dishes were sterilized by soaking in 70%
pure ethanol bath for 1 h, air-dried, and then rinsed in the
medium once before use. Exponentially growing NHLF cells
were plated in the concentric strip dishes 3 days before irradi-
ation to ensure a confluent state. Because the fibroblasts seeded
on the 38-m-thick mylar strips would not be irradiated due to
the short penetrating distance of the  particles, these cells would
effectively become the bystander cells, being seeded right next to
the cells plated on the 6-m mylar dishes that were directly
irradiated (Fig. 1). A 50-cGy dose of 4He ions (120 keVm) was
delivered to the NHLF cells by using the 4-MV van de Graff
accelerator at the Radiological Research Accelerator Facilities
of Columbia University, as described (4, 10, 13–15). After
irradiation, at selected time points, the inner and outer mylar
dishes were separated, and the cells from each growth surface
were trypsinized and individually pooled for endpoint analysis.
Survival of Irradiated and Nonirradiated Bystander Cells. Nonirradi-
ated bystander, irradiated, and control cells were collected after
irradiation at different time points. Cultures were trypsinized,
counted with a Coulter counter, and aliquots of the cells were
replated into 100-mm-diameter dishes for colony formation.
Representative aliquots of cells were further incubated for
mutation assay, cDNA expression array analysis, and Western
blot. Cultures for clonogenic survival assays were incubated for
12 days, at which time they were fixed with formaldehyde and
stained with Giemsa. The number of colonies was counted to
determine the surviving fraction as described (10, 13).
Quantification of Mutations at the HPRT Locus. To determine the
mutant fraction, after a 7-day expression period, 2 105 cells per
dish were plated into 25–30 100-mm dishes in a total of 12 ml of
the growth medium, with 100 M 6-thioguanine (6-TG, Sigma).
The cultures were further incubated for 12 days, at which time
the cells were fixed and stained and the number of HPRT
mutant colonies scored. Meanwhile, aliquots of 500 cells were
plated in dishes containing growth medium without 6-TG for
determination of the plating efficiency. The cultures derived
from each group were tested for mutant yield for 2 consecutive
weeks to ensure full expression of the mutations. The mutant
fraction was calculated as the number of surviving colonies
divided by the total number of cells plated after correction for
the plating efficiency.
cDNA Microarray. The signal transduction pathway finder array
(SuperArray, Frederick, MD), which includes 96 genes involved
in 18 different signal transduction pathways, was used in the
experiments. RNA from control, bystander, and irradiated cells
were extracted by using TRIzol reagent (Invitrogen), and the
same amount of total RNAwas used for each array according the
protocol provided by the manufacturer (26, 27).
RT-PCR. The Advantage RT-PCR Kit (BD Biosciences, Franklin
Lakes, NJ) was used for RT-PCR analysis. Briefly, cDNA was
synthesized from 0.8 g of total RNA based on the protocol
provided. Five microliters of the diluted cDNAwas used for each
50-l PCR reaction. The efficiency of cDNA synthesis was
estimated by using GAPDH as a positive internal control.
Primers for COX- 2 were: sense, GCTTCCATTGCCAGAG-
CAGGCA; antisense, GAGCTCTGGATCTGGAACACTG;
and for insulin growth factor (IGF)-binding protein-3 (IGFBP-
3), sense, ACTTCTCCTCCGAGTCCAAGCG; antisense,
CGCTTCGACCAACATGTGGTGAGC.
Western Blotting. Protein was extracted from either control or
bystander cells by lysis in extracting buffer (50 mM TrisHCl (pH
8)150 mM NaCl1% Nonidet P-400.1% SDS1 mM phenyl-
methylsulfonyl f luoride, and mixture of protease inhibitors
(Roche Applied Sciences, Indianapolis, IN). The concentration
of the protein was determined by Bio-Rad Protein Assay (Bio-
Rad). Equivalent amounts of protein (100 g) were fractionated
on 10% SDS polyacrylamide gel overnight, and proteins were
transferred to nitrocellulose membranes under semidry condi-
tions. For the COX-2 study, the primary antibodies used were
goat polyclonal anti-human COX-2 (Santa Cruz Biotechnology).
COX-2 protein was detected by using horseradish peroxidase
Fig. 1. A schematic diagram of the stripped dish used in the present study.
A 6-m-thick mylar sheet was epoxied to the outer stainless ring to provide a
bottom for the dish. The mylar of the inner rings (38m thick) was cut as strips.
Exponentially growing NHLF cells were plated into the concentric rings 2 days
before irradiation at a density to ensure a confluent state. (See Materials and
Methods for further details.)
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(HRP)-conjugated donkey anti-goat IgG diluted 1:10,000 in 5%
skim milk in TBS-Tween for 60 min at room temperature. For
MAPK pathways, the primary antibodies used were polyclonal
anti-phospho p4442 MAPK (Thr-202Tyr-204), anti-p4442
MAPK, anti-phospho-p38 MAPK (Thr-180Tyr-182), anti-p38
MAPK (Cell Signaling Technology, Beverly, MA) and mono-
clonal anti--actin (Sigma). The secondary antibodies (anti-
rabbit, anti-mouse, or anti-goat) were conjugated to HRP (di-
lution 1:5,000–1:10,000). After incubation, the band intensities
were evaluated by phosphorimaging and normalized to the
-actin expression level.
Statistical Analysis. Data were calculated as means and standard
deviations. Comparisons of surviving fractions and induced
mutant fractions between treated and control groups were made
by the students’ t tests. A P value of 0.05 between groups was
considered significant.
Results
Bystander Cytotoxicity and Mutagenesis in NHLF Induced by  Parti-
cles by Using Double Mylar Dishes. In our quest to identify the
signaling pathways involved in radiation induced bystander
effect, we first focused on the genes that are differentially
expressed among the bystander vs. control cells. Because the
microbeam can irradiate only one cell at a time, and a large
number of cells are needed for gene array analyses, we used the
double mylar dish approach (described above) to define the
bystander response. Fig. 2 shows the cytotoxicity and mutagen-
esis at the HPRT locus for primary human lung fibroblasts that
either are directly irradiated (seeded on the 6-m mylar) or are
bystander cells (seeded in the 38-mmylar). Consistent with our
previous findings, NHLF irradiated with a 0.5-Gy dose of 
particles resulted in a survival level of 0.21  0.07 (Fig. 2A) and
a mutant fraction of 8.4  2.2 mutants per 106 survivors (Fig.
2B). In contrast, the nonirradiated bystander cells showed a
reduced surviving fraction of 0.76  0.11, a level that was
significantly differed from the nontreated controls (P  0.05).
Similarly, nonirradiated bystander NHLF showed increased
HPRT mutagenesis (3.2  1.4 mutants per 106 survivors) at a
level significantly higher than the background mutant fraction of
0.4  1.1 (P  0.05).
Use of Gene Array to Identify Differentially Expressed Genes Among
Bystander vs. Control Cells.By using a signal transduction pathway-
specific SuperArray, we compared the differentially expressed
genes among the nonirradiated control NHLF and bystander
cells (Fig. 3A). Among the 96 genes represented on the platform,
transcription level of one gene, COX-2, was found to be consis-
tently up-regulated by 3-fold, whereas the RNA level of
IGFBP-3 was found to be consistently lower by 7-fold in
multiple analyses of multiple bystander samples. Semiquantita-
tive RT-PCR was used to confirm the expression levels of these
two genes by using expression level of the GAPDH gene as
internal control (Fig. 3B). The expression of the COX-2 protein
in the nonirradiated bystander cells was further confirmed by
Western blotting (Fig. 3C). Addition of the COX-2 inhibitor
NS-398 (50 M) suppressed COX-2 level in NHLF cells. After
24 h, the COX-2 protein in bystander cells was reduced to a
nondetectable level (lane 2 vs. lane 4). These results indicated
that expression of COX-2 is associated with the bystander effect.
Because the COX-2 gene plays an important role in arachidonic
acid metabolism, the discovery is consistent with the finding that
TGF may be linked to the bystander signaling cascade (23).
Effects of COX-2 Inhibitor on the Bystander Effect. If the COX-2 gene
is causally linked to the bystander signaling pathways, it should
be possible to modulate the bystander response by using a
specific inhibitor of the COX-2 enzymatic activity. Fig. 4 shows
the effect of a noncytotoxic and nonmutagenic dose of NS-398,
a specific inhibitor of COX-2 activity, on bystander mutagenesis
at the HPRT locus in NHLF cells irradiated with a 0.5-Gy dose
of  particles by using the track segment beam. NHLF cells
showed a bystander mutagenic yield of 4.2  1.2 mutants per
106 survivors. In contrast, in cultures cotreated with NS-398 (50
M) that did not increase the spontaneous mutant yield by itself,
the bystander mutant fraction was reduced by 6-fold to a level
of 0.7  0.2 mutants per 106 survivors. Although NS-398
treatment was able to reduce the HPRT mutant fraction in the
directly irradiated population as well, the magnitude of suppres-
Fig. 2. Survival fraction and HPRT mutations in bystander and directly irradiated cells. Cultures were irradiated with a 0.5-Gy dose of  particle radiation by
using the stripped dishes. Data are pooled from six to eight independent experiments. Bar represents  SD.
Fig. 3. Identification of differentially expressed genes in radiation-induced
bystander cells. (A) Differentially expressed signaling genes in bystander and
control normal human lung fibroblasts using the cDNA signal transduction
pathway finder array (SuperArray). (B) RT-PCR analysis and confirmation of
the array data showing down-regulated IGFBP-3 and up-regulated COX-2. (C)
Western blotting of COX-2 protein expression (72 kD) in bystander and control
cells with or without treatment with NS 398 (50M), a specific COX-2 inhibitor.








sion, from 9.2  3.5 to 5.9  2.2 mutants per 106 survivors was
only 36%. Similar findings were also obtained by using cytotox-
icity as an endpoint (data not shown).
Effects of IGFBP-3 on the Bystander Effect. IGFBP-3 inhibits IGF
signaling activity at the cellular level by competitively binding
IGFs and, as a result, decreases their ability to bind to the cell
surface receptor. Because bystander cells show a 7-fold decrease
in the levels of IGFBP-3 RNA, we hypothesize that IGFmay play
an important role in mediating the bystander effect. As a result,
the addition of exogenous IGFBP-3 may suppress the bystander
effect. Fig. 5 shows the effects of exogenously applied IGFBP-3
(1 gml) on both bystander survival as well as HPRT mutant
fraction in NHLF cells. Addition of IGFBP-3 increased the
bystander survival from 0.68 0.11 to 0.81 0.13, although the
result was not statistically significant (P  0.05). In contrast,
addition of IGFBP-3 reduced the mutant yield by 4-fold from
3.9 to 0.9 mutants per 106 survivors. It should be noted that the
bystander mutant fraction obtained in this set of experiments
was comparable to that of the COX-2 studies described above.
Activation of MAPK Signaling Pathways in Bystander Cells. IGF and
other cytokines activateMAPK signaling cascade, and activation
of ERK by phosphorylation is a critical upstream event preced-
ing COX-2 expression. Determination of ERK activity by West-
ern blot analysis demonstrated strong up-regulation of phospho-
ERK levels in both  irradiated and bystander NHLF 4 h after
treatment (Fig. 6A). Increased levels of phospho-ERK could
even be detected 16 h after treatment, indicating a persistent
response to the bystander signaling (data not shown). In con-
trast, activity of MAPK p38 kinase was found to be increased 4 h
after treatment (Fig. 6A) and was not detectable 16 h after
irradiation (data not shown). It should be noted that, when
compared with the controls, the ratio of phosphorylated ERK
over native ERK increased from 2 to 13 among the bystander
cells. To further confirm the activation of ERK in bystander
cells, we used PD 98059 (50 M), a specific inhibitor of MAPK
kinase (MEK)-ERK, which had been added to cell cultures
immediately after irradiation for a period of 4 h. In the presence
of PD 98059, the phosphorylated form of ERK and its activation
were suppressed in both  particle-irradiated and bystander cells
(Fig. 6B). Because NHLFs respond to different forms of stress,
including radiation, by up-regulation of the production of various
cytokines, we used inhibitory anti-TNF- monoclonal antibody
to determine the probable role of TNF- in bystander activation.
This mAb (2 gml), which had been added immediately after
irradiation, significantly blocked ERK activation in bystander
cells, whereas effects on irradiated cells were very mild (Fig. 6C).
Down-regulation of ERK activity in bystander cells in the
presence of PD98059 (50 M) completely suppressed COX-2
expression (Fig. 6D).
Inhibition of ERK Signaling Suppresses the Bystander Response. If
activation of the MAPK signaling cascade and ERK phosphor-
ylation are essential in mediating the bystander effect, it should
be possible to mitigate the later response by using a specific
inhibitor of the MEK-ERK signaling cascade. Fig. 7 shows the
bystander toxicity in the presence or absence of a noncytotoxic
dose of PD 98059 (50 M) when added to cultures immediately
after irradiation for a period of 4 h, as described above. The
surviving fraction of the bystander cells was 0.72  0.1, and
treatment with PD 98059 increased survival significantly to
almost control level, 0.95  0.12 (P  0.05).
Conclusion
Radiation-induced bystander effects have been extensively stud-
ied in the past decade. The plethora of data now available
concerning this effect falls into two categories: (i) in confluent
cultures where physical contacts between irradiated and nonir-
radiated cells are made and where gap junctional communica-
tions have been shown to be essential for the process, and (ii) in
sparsely populated cultures where bystander effects may be
mediated by damage signals released into the culture medium by
the irradiated cells. As a result, incubation of nonirradiated cells
with conditioned medium from irradiated cultures may lead to
induction of biological effects. In the present study, spatially
distinct confluent monolayers of NHLF were used. It is not clear
whether the signaling molecules involved in the two bystander
Fig. 4. Effect of NS 398 treatment (50 M, 24 h before and maintained
overnight after irradiation), a specific COX-2 inhibitor, on HPRT mutant
fractions of NHLFs. Data are from three to four independent experiments. Bar
represents  SD.
Fig. 5. Effect of IGFBP-3 treatment (1 gml, 24 h before and maintained overnight after irradiation) on survival fraction (Left) and HPRT  mutation fraction
(Right) in control and bystander NHLF cells in the vicinity of cells irradiated with 0.5-Gy  particle plated in strip dishes. Data are pooled from three independent
experiments. Bar represents  SD.
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processes are mutually exclusive. In fact, it is likely that some
common initiating or intermediate steps are involved.
The mechanism of the radiation-induced bystander effect,
whether involving cell–cell contact or mediated by soluble
factors, is not clear, is likely to be complex, and involves multiple
pathways. It is, however, clear that p53 gene function is not
necessary for the effect, because cells without normal p53
function (such as Chinese hamster ovary cells) show a large
bystander response in either bystander pathway. It is likely that
multiple signaling cascades involving both an initiating event and
downstream signaling steps are necessary to mediate the by-
stander process. In the present study, we have used a systematic
approach to first identify the signaling genes that are differen-
tially altered among the bystander cells, followed by functional
assays to identify and assess the biological significance of the
signaling molecules.
By using a microarray specific for cell signaling genes, we
identified the transcription of two genes, COX-2 and IGFBP-3,
that were consistently altered in the bystander cells. As proposed
in our working model (Fig. 8), the functions of these two genes
might work in a coordinated manner to mediate the bystander
effect. COX-2 is a member of the COX family of genes that have
important functions in mediating the cellular immune response.
There are two isoforms of COX:COX-1 andCOX-2, which differ
in many respects. For example,COX-1 is constitutively expressed
in normal tissues, but COX-2 is inducible after treatment with
different growth factors and cytokines, such as TGF, TNF-,
IL1, and different stress factors (28, 29). All these stimuli
induceRas-Raf-MEK-ERK-AP1 and inhibitor nuclear factor B
kinase (IKK)-NF-B pathways and finally target COX-2 gene
transcription. COX-2 is the initial and rate-limiting enzymatic
step in the metabolism of arachidonic acid into a complex group
of signaling lipid mediators called prostaglandins (30), which
play important roles in modulating cellular inflammation, car-
cinogenesis and genomic instability.
Fig. 6. Activation of the MAPK signaling pathways is involved in the radia-
tion-induced bystander effects. Western blot analysis of phospho-ERK12,
total ERK12, phospho-p38, and total p38 expression in control, -irradiated,
and bystander NHLF cells 4 hr after irradiation with a 0.5-Gy dose of  particle
plated in stripped dishes (A). -actin was used as a loading control. Phospho-
ERKERK ratio is indicated. PD 98059 (50 M), an inhibitor of MEK-ERK, was
added to the cultures immediately after irradiation (B). Anti-TNF- mAb (2
gml) was added to the cultures immediately after irradiation (C), PD98059
(50 M) suppressed expression of COX-2 in bystander cells (D).
Fig. 7. Effect of PD 98059 treatment (50 M, immediately after and main-
tained overnight after irradiation), an inhibitor of MEK-ERK, on surviving
fractions of control, directly irradiated, and bystander NHLF cells. Data are
from three independent experiments. Bar represents  SD.
Fig. 8. Working model of the signaling pathways involved in the radiation-
induced bystander effect. Binding of TNF-, TGF, IGF, IL-1, and IL-8 ligands to
the corresponding receptors activate signaling pathways including MEK12;
mitogen-activated protein kinase kinase (MKK36), and p38 kinase (all in blue
lines), which lead to COX-2 gene expression. Specific inhibitors of the various
signaling pathways, such as Wortmannin (wt) for phosphatidylinositol 3-ki-
nase andN-()-tosyl-L-lysine chloromethylketone hydrochloride for the NF-B
can be used to delineate specific signaling routes involved in the bystander
phenomenon.








Because the abundance of COX-2 RNA is increased by 3-fold
in the bystander cells, it is necessary to neutralize the COX-2
signaling pathways to establish its function in the bystander
effect. We used NS-398, a specific inhibitor of COX-2, to achieve
this goal. The IC50 values of NS-398 for the human recombinant
form of COX-1 and COX-2 have been established to be 75 and
1.8 M, respectively (31). In the presence of NS-398, the
bystander mutagenic effect was reduced by 6-fold in NHLF
cells, thereby establishing the functional link of COX-2 to the
bystander cascade of events. However, because both directly
irradiated and nonirradiated bystander NHLF cells were main-
tained in the same medium with NS-398, we cannot rule out the
possible effects of NS-398 on the directly irradiated cells in
promoting radiation-induced bystander effects.
Another gene found to be differentially expressed in the by-
stander NHLF cells is IGFBP-3. In humans, the majority of the
circulating IGFs are bound to IGFBP-3, which is produced mainly
in the liver (32). IGFBP-3 inhibits IGF activity at the cellular level
by binding competitively to IGFs and, thereby, preventing their
binding to the IGF receptors in the cell surface. By preventing IGFs
from binding to the IGF receptors, IGFBP-3 effectively inhibits
IGF-mediated signaling pathways (33). The observation that there
was a 7-fold decrease in levels of IGFBP-3 among the bystander
cells suggests that the IGF signaling process is active and could
potentially play a functional role in the bystander process. Our
findings that exogenously applied IGFBP-3 can eliminate both
bystander survival andmutagenic effects provide strong support for
an important role of the IGF activating loop. This finding is
consistent with our observations that pretreatment with anti-
human TNF- monoclonal antibody (5 gml), which does not
affect ERK phosphorylation in irradiated fibroblasts, completely
abolished ERK activation in the bystander cells.
As mentioned above, one of the consequences of the binding of
TNF-, IGF, and other leukotrienes to the surface receptor sites is
activation of the MAPK cellular signaling pathways. The three
classes of MAPK include ERK, c-Jun N-terminal kinase (JNK),
and p38 kinases (34). ERKs are believed to be strongly activated
and to play an important role in intracellular signaling induced by
various growth factors, such as epidermal growth factor and tumor
promoters (e.g., phorbol esters) (35). On the other hand, JNK and
p38 kinases are activated bymultiple stresses includingUV, ionizing
radiation, cytotoxic chemicals, and reactive oxygen species (36).
Although the role of p38 kinase signaling in the cellular response
to external stimuli is diverse, responses of ERK and JNK are fairly
reliable. This is consistent with our present finding, where the
activation of ERK is robust and persistent.
Furthermore, there is evidence that TGF may play an
important role in mediating bystander effects in medium-
transfer experiments (23). Similarly, Lehnert et al. (37, 38) have
demonstrated the contribution of reactive oxygen species (ROS)
to the induction of sister chromatid exchanges among nonirra-
diated cultures exposed to irradiated culture media. Because
both TGF and ROS can trigger the MAPK signaling cascade,
these findings are consistent with the present observation of the
role of COX-2 in the bystander effect. Likewise, the role of nitric
oxide in medium-mediated bystander response has been de-
scribed (24). The observations that (i) nitric oxide is known to
regulate the expression of IL-8 in some human cells (39) and (ii)
nitric oxide synthase, which is critical to the biosynthesis of
peroxynitrite anions, has been shown to be involved in the
regulation of COX-2 expression (40) provide a functional link
for the role of nitric oxide and COX-2 in mediating the bystander
effect. It is likely that some common initiating or intermediate
steps are involved in the two processes.
Last, a better understanding of the cellular and molecular
mechanisms of the bystander phenomenon, together with evi-
dence of their occurrence in vivo, will allow us to formulate a
more accurate model in assessing the health effects of low doses
of ionizing radiation.
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